Health Care/Hospital

Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success

* To be registered as an official research organization by the National Assembly Secretariat... Expected to become Korea's leading medical think tank * Planning to initiate global multinational clinical projects in digital therapeutics * Establishing a future medical system centered aroun...

2024-04-19 21:00 2958

Concord Medical Files 2023 Annual Report on Form 20-F

BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it filed its annual report on Form 20-F for t...

2024-04-19 20:31 2924

MGI Tech's DNBSEQ-T20x2* Gene Sequencer Named 2024 Edison Award™ Gold Winner

FORT MYERS, Fla., April 19, 2024 /PRNewswire/ -- MGI Tech , a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a GoldEdison Award

2024-04-19 20:15 1561

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-19 19:00 4086

GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer

SHANGHAI, April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a mult...

2024-04-19 19:00 2184

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com ) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue vi...

2024-04-19 13:17 2267

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com ) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue...

2024-04-19 10:54 2280

EARTHDAY.ORG PARTNERS WITH OAAA TO BRING AWARENESS TO THE DANGERS OF PLASTICS TO HUMAN HEALTH

WASHINGTON, April 19, 2024 /PRNewswire/ -- EARTHDAY.ORG, the global force behind Earth Day, is partnering with the Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry,  for the sixth year in a row! OAAA and ...

2024-04-19 01:45 2036

Milliken & Company Releases 2023 Sustainability Report

Company discloses assessment of sustainability metrics and targets SPARTANBURG, S.C., April 18, 2024 /PRNewswire/ -- Diversified global manufacturer Milliken & Company today released itssixth annual sustainability report that discloses performance against its 2025 Sustainability Goals and 2030 n...

2024-04-18 21:15 2040

Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions

Using patient personality traits to pioneer a new era in clinical research. MONT-SAINT-GUIBERT, Belgium, April 18, 2024 /PRNewswire/ -- Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly announces a...

2024-04-18 21:00 2433

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

GAITHERSBURG, Md., April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-18 20:00 1623

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

HEIDELBERG, Germany, April 18, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has announced substantial advances in Down Syndrome research, revealing new neuroanatomi...

2024-04-18 16:17 1777

FWD Hong Kong employees fuel changes with every step for Weez Walk 2024: Standing strong for youth mental health

HONG KONG, April 18, 2024 /PRNewswire/ -- Weez Walk 2024 ("Weez Walk"), organised by Weez Project and KELY Support Group (collectively "the organisers") and sponsored by FWD Hong Kong ("FWD"), was recently concluded with remarkable success. The event attracted over 820 participants, united in th...

2024-04-18 15:40 1916

Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement

BANGKOK, April 18, 2024 /PRNewswire/ -- Siriraj Hospital, a leading healthcare institution inThailand, stands at the forefront of aortic valve disease treatment with Transcatheter Aortic Valve Implantation (TAVI). The minimally invasive procedure significantly reduces surgical trauma and post-sur...

2024-04-18 15:01 2269

TaiGen Successfully Completes TG-1000 Phase III Study

TAIPEI, April 17, 2024 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to alleviation of al...

2024-04-18 11:03 1551

Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"

MELBOURNE, Australia, April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubatorJumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaitedMelbourne-based facility at an ...

2024-04-18 11:00 2080

Datasea Secures Combined $15 Million with its Second Sales Contract for Acoustic Products

BEIJING, April 17, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada, dedicated to innovative business in acoustic high tech and 5G-Artificial Intelligence ("AI") multimodal communication technology inthe United State...

2024-04-17 22:00 1561

Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity

SHANGHAI, April 17, 2024 /PRNewswire/ -- On April 17, 2024, Henlius (2696.HK) released its 2023 Environmental, Social and Governance (ESG) report (hereinafter referred to as "ESG report" or "report"). The report comprehensively discloses the Company's initiatives and achievements in promoting is...

2024-04-17 20:32 1806

One hundred days to the Games: Transport plan ready

PARIS, April 17, 2024 /PRNewswire/ -- The Île-de-France region and Île-de-France Mobilités, as the leading public financiers, after the Government, have invested more than €500 milliontowards the Paris 2024 Olympic and Paralympic Games. This investment encompasses transport, sports infrastructur...

2024-04-17 20:00 2340

Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Health Intelligence Enabling Real-Time Tracking of Medical Device Markets

New solution offers comprehensive tracking and analysis of market share and size inBrazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON, April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released itsLatAm market ...

2024-04-17 16:00 2034
1 ... 99100101102103104105 ... 848

Week's Top Stories